Published in
Wiley, European Journal of Heart Failure, 10(24), p. 1892-1901, 2022
DOI: 10.1002/ejhf.2652
Links
Tools
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
Journal article published in 2022 by
John W. Ostrominski 
,
Muthiah Vaduganathan ,
Brian L. Claggett,
Rudolf A. de Boer ,
Akshay S. Desai ,
Dan Dobreanu,
Adrian F. Hernandez,
Silvio E. Inzucchi,
Pardeep S. Jhund ,
Mikhail Kosiborod,
Carolyn S. P. Lam,
Anna M. Langkilde,
Daniel Lindholm ,
Felipe A. Martinez,
Eileen O'Meara
and other authors.
,
Muthiah Vaduganathan ,
Brian L. Claggett,
Rudolf A. de Boer ,
Akshay S. Desai ,
Dan Dobreanu,
Adrian F. Hernandez,
Silvio E. Inzucchi,
Pardeep S. Jhund ,
Mikhail Kosiborod,
Carolyn S. P. Lam,
Anna M. Langkilde,
Daniel Lindholm ,
Felipe A. Martinez,
Eileen O'Meara
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 